Notice2023-19065

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 5, 2023

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 170 (Tuesday, September 5, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 170 (Tuesday, September 5, 2023)]
[Notices]
[Pages 60684-60685]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-19065]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-23FQ]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Public Health/Public Safety Strategies to 
Reduce Drug Overdose Data Collection'' to the Office of Management and 
Budget (OMB) for review and approval. CDC previously published a 
``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on June 09, 2023 to obtain comments from the 
public and affected agencies. CDC did not receive comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and

[[Page 60685]]

    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Public Health/Public Safety Strategies to Reduce Drug Overdose Data 
Collection--New--National Center for Injury Prevention and Control 
(NCIPC), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The drug overdose epidemic continues to pose a serious threat to 
communities across the country. In March 2023, the declaration of the 
opioid crisis as a national public health emergency was renewed yet 
again. Further, provisional data from the National Center for Health 
Statistics confirmed that the number of overdose deaths in 2022 was 
109,680, which is a 0.5% increase from 2020. Adding to this challenge, 
drug availability and overdose trends are rapidly changing, shaped by 
the westward expansion of fentanyl, the eastward expansion of 
methamphetamine, the inclusion of adulterants in the drug supply (e.g., 
fentanyl, xylazine), and increasing polysubstance-involved overdose.
    Multisector collaboration is critical to saving lives and reducing 
the overdose epidemic. Two key sectors in this response are public 
health and public safety (PH/PS), as they are both on the front lines 
and both tasked with improving community safety and well-being. CDC 
demonstrates strong commitment to PH/PS partnerships through 
implementation of several national programs. Beginning in September 
2019, CDC's Overdose Data to Action (OD2A) funds enhanced surveillance 
and prevention of fatal and nonfatal opioid overdoses in 47 States and 
19 localities. In most of these jurisdictions, prevention activities 
are carried out in partnership with public safety. Since 2017, CDC has 
supported the Overdose Response Strategy (ORS), a unique collaboration 
between public health and public safety partners created to help local 
communities reduce drug overdose and save lives. CDC recently launched 
the Opioid Rapid Response Program, an interagency, coordinated Federal 
effort with the HHS Office of Inspector General to help mitigate 
overdose risks among patients who lose access to a prescriber of 
opioids due to law enforcement actions. As a relatively new and 
increasingly leveraged tool for overdose prevention, a greater 
understanding of PH/PS strategies are needed to inform these national 
programs.
    The goal of this Generic Clearance mechanism (Generic ICR, GenIC) 
is to collect data to improve overdose prevention efforts that involve 
PH/PS sectors or address justice-involved populations at increased risk 
of overdose. This requires practical information and experiential 
knowledge on current implementation of overdose prevention efforts by 
PH/PS. Based on previous experience, NCIPC anticipates that information 
will need to be collected to: (a) understand the design, 
implementation, and uptake of strategies that involve public health and 
safety, or individuals involved in the criminal legal system who are at 
increased risk of overdose; (b) identify barriers, facilitators, and 
best practices associated with strategy implementation; and, (c) 
identify disparities in access to strategies among diverse populations 
or the effectiveness of these strategies in reducing overdose.
    This Generic Clearance will allow for the gathering of information 
about PH/PS strategies to identify actions to improve responses to the 
overdose crisis. No mechanism currently exists that would allow for 
exploration of programs, practices, and capacity among PH/PS 
partnerships to address overdose. The assessments conducted and 
information gathered through this Generic Clearance will be used to 
rapidly improve the implementation of programs enacted through these 
partnerships throughout the lifespan of CDC's national programs. The 
estimated annual burden hours for this collection are 2,500. There are 
no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of      Average burden
         Type of respondent                  Form name            Number of      responses per     per response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
Public Health/Public Safety           Public Health/Public              5,000                1            30/60
 Strategies Data Collection            Safety Strategies Data
 Participants.                         Collection Instruments.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-19065 Filed 9-1-23; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on September 5, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.